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Abstract
Background: The possibility exists for major complications to occur when individuals are intoxicated
with alcohol prior to anesthetization. Halothane is an anesthetic that can be metabolized by the liver into
a highly reactive product, trifluoroacetyl chloride, which reacts with endogenous proteins to form a
trifluoroacetyl-adduct (TFA-adduct). The MAA-adduct which is formed by acetaldehyde (AA) and
malondialdehyde reacting with endogenous proteins, has been found in both patients and animals
chronically consuming alcohol. These TFA and MAA-adducts have been shown to cause the release of
inflammatory products by various cell types. If both adducts share a similar mechanism of cell activation,
receiving halothane anesthesia while intoxicated with alcohol could exacerbate the inflammatory response
and lead to cardiovascular injury.
Methods: We have recently demonstrated that the MAA-adduct induces tumor necrosis factor-α  (TNF-
α ) release by heart endothelial cells (HECs). In this study, pair and alcohol-fed rats were randomized to
receive halothane pretreatments intra peritoneal. Following the pretreatments, the intact heart was
removed, HECs were isolated and stimulated with unmodified bovine serum albumin (Alb), MAA-modified
Alb (MAA-Alb), Hexyl-MAA, or lipopolysaccharide (LPS), and supernatant concentrations of TNF-α  were
measured by ELISA.
Results: Halothane pre-treated rat HECs released significantly greater TNF-α  concentration following
MAA-adduct and LPS stimulation than the non-halothane pre-treated in both pair and alcohol-fed rats, but
was significantly greater in the alcohol-fed rats.
Conclusion: These results demonstrate that halothane and MAA-adduct pre-treatment increases the
inflammatory response (TNF-α  release). Also, these results suggest that halothane exposure may increase
the risk of alcohol-induced heart injury, since halothane pre-treatment potentiates the HEC TNF-α  release
measured following both MAA-Alb and LPS stimulation.
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Background
Anesthetics like halothane are rarely used in most nations
except in developing countries, which still widely use this
method of anesthesia [1]. Also on the rise is alcohol con-
sumption in developing countries [2]. Patients consum-
ing alcohol who are anesthetized with halothane could
potentially have inadequate metabolism or adduct forma-
tion leading to problems such as cardiovascular disease or
liver injury. Hepatic metabolism of halothane and
ingested ethanol (ethyl alcohol, alcohol) yields the highly
reactive metabolites: trifluoroacetyl chloride (TFA) from
halothane and acetaldehyde (AA) and malondialdehyde
(MDA) from the oxidation of ethanol [3,4]. MDA and AA
react together with endogenous proteins (most likely the
ε -amino group of lysine residues) to form distinctive new
adducted proteins [3,4]. The adduct formed by the combi-
nation of MDA and AA has been termed the MAA-adduct
by Tuma et al [4] and has been detected in humans and
rats chronically consuming ethanol [5,6]. In fact, Slatter et
al [7] have recently confirmed that MDA, AA, and lysine
react to form a dihydropyridine derivative structurally
identical to the MAA-adduct. Similarly, trifluoroacetyl
chloride (TFA) will react with amine groups to form a dis-
tinctive protein termed the TFA-adduct [8].
Recent reports by our laboratory have demonstrated that
the MAA-adduct will induce the release of the proinflam-
matory cytokine tumor necrosis factor-alpha (TNF-α ) in a
purified rat heart endothelial cell culture (HEC) [9].
Trudell et al [3] reported data suggesting that the TFA-
adduct may cause cell injury by inducing a similar inflam-
matory response. Importantly, it has been demonstrated
that the TFA-adduct is present in heart tissue obtained
from halothane pre-treated rats [10,11]. If both adducts
share a similar mechanism of cell activation, receiving
halothane anesthesia while intoxicated with alcohol
could exacerbate the inflammatory response. Also of
interest is that both halothane and ethanol are metabo-
lized through cytochrome P450 2E1 (CYP2E1) [12], pos-
sible providing a shared mechanism. In support of this is
data suggesting that acetaldehyde effects ventricular myo-
cyte contraction through mechanisms related to CYP oxi-
dase and lipid peroxidation [13]. This could help explain
how ethanol consumption and halothane anesthesia
could enhance the sensitization of an individual to
halothane and MAA adducts, thereby increasing their risk
to cardiovascular disease.
Therefore, we hypothesize that halothane pre-treatment
may potentiate the inflammatory response induced by the
MAA-adduct as determined by TNF-α  release. Thus, this
rat-model study evaluates the effects of halothane pre-
treatment in combination with an alcohol diet on in vitro




Bovine serum albumin (Alb) was purchased from CalBio-
chem (La Jolla, CA). Acetaldehyde (AA) was obtained
from Aldrich Chemical Co. (Milwaukee, WI). Malondial-
dehyde (MDA) was obtained as the sodium salt
(MDA~Na) by treatment of tetramethoxypropane
(Aldrich Chemical Co.) with NaOH, according to the
method of Kikugawa and Ido [14]. Lipopolysaccharide
and Eschericahia coli 0111:B4 (LPS) was purchased from
Sigma Chemical Co. (St. Louis, MO). Halothane was pur-
chased from Halocarbon Laboratories (River Edge, NJ).
Production of the malondialdehyde-acetaldehyde adduct
MAA-Alb was prepared as described by Tuma et al. [15]
Briefly, Alb was modified with 1 mM malondialdehyde
(MDA) and 1 mM acetaldehyde (AA) by incubating at 37
degrees for 72 hours. Following incubation, free and
reversibly-bound MDA or AA was separated by exhaustive
dialysis against a phosphate buffer for 24 hours at 4
degrees. Fluorescence measurements were obtained on
post dialysis samples using a Perkin Elmer (Norwalk, CT)
LS-5B spectrophotofluorometer attached to a Perkin
Elmer GP-100 graphics printer as previously described
[15]. Protein concentrations were measured as described
by Bradford [16].
Animal preparation
Male Wistar rats purchased from Charles River Laborato-
ries (Willmington, MA) were maintained on a Purina rat
chow diet, until they reached a weight of 140–150 grams,
and were divided into three groups. These three groups
were housed individually and acclimated to the Lieber-
DeCarli liquid control diet from Dyets, Inc. (Bethlehem,
PA) for 3 days [17]. The rats were paired by weight, one rat
was given the ethanol-containing diet ad libitum, and the
other rat was fed an isocaloric amount of the control liq-
uid diet as determined by the pair-fed rat from the day
before. Pair feeding was continued for 6 weeks. Finally,
the ethanol-containing diet consisted of 18% of the total
calories as protein, 35% as fat, and 36% as ethanol. In the
control liquid diet, ethanol was replaced isocalorically
with carbohydrates. The final group was given free access
to standard laboratory chow and water.
For adduct immunization rats were injected once per
week for 3 consecutive weeks beginning on day fourteen
with one of the following protocols: (1) An injection of
Alb only (25 µg/ml) subcutaneously plus an i.p. injection
of an equal volume of sesame oil were given to control
animals.; (2) halothane as a 21.5% solution in sesame oil
at a dose of 10 mmol/kg intraperitoneally (i.p.);. (3)
MAA-Alb (25 µg/ml) subcutaneously (s.c.); or (4) MAA-
Alb and halothane combined in the previously men-
tioned doses. After one month (day twenty nine) on theirBMC Anesthesiology 2005, 5:3 http://www.biomedcentral.com/1471-2253/5/3
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respective diets, and 24 hours following the final injection
of Alb, halothane (i.p.), MAA-Alb (s.c.), or MAA-Alb (s.c.)
and halothane (i.p.) combined, the rats were sacrificed,
and hearts removed for use in in vitro studies as described
below. All animals were allowed free access to their food
and/or water up to 1 hour before sacrifice. All procedures
were approved by the animal subcommittee of the
Omaha VA Medical Center, and are in accordance with the
National Institutes of Health Guidelines on the Use of
Laboratory Animals.
Transaminase assay
Animals injected with the above ligands were bleed prior
to sacrifice and serum transaminase enzymes determined
using an (ALT/GPT and AST/GOT) assay kit purchased
from Sigma Diagnostics (St. Louis, MO).
Isolation and culture of heart endothelial cells (HECs)
Male Wistar rats were anesthetized intraperitoneal with
phenobarbital (100 mg/kg) and the intact beating heart
was immediately removed under sterile conditions. After
mincing and dispase digestion, heart endothelial cells
(HECs) were isolated and grown to confluency as previ-
ously described [9,18]. In brief, HECs were separated by
centrifugation at 400 × g for 10 min followed by three
washes with M199-F12 (GIBCO, Grand Island, NY) con-
taining 10% fetal bovine serum (GIBCO). Cells collected
were >90% HECs, verified by staining with mouse anti-rat
RECA-1 (Harlan Bioproducts for Science, Indianapolis,
IN) and mouse anti-Factor VIII-von Willebrand's Factor
(Cedar Lane Laboratories Limited, Hornby, Ontario, Can-
ada) [9]. Cells were seeded into 24 well tissue culture
plates (Becton-Dickinson Labware, Franklin Lakes, NJ)
containing fibronectin (20 µg/well) (Sigma Chemical
Company, St. Louis, MO) and grown to confluency at
37°C for 48–72 hours.
Percentage of cell necrosis determinations
The percentage of cell necrosis (death) of HECs during
exposure to MAA-Alb was determined by an enzyme (lac-
tic acid dehydrogenase, LDH) release assay of the HEC
supernatant as described by Korzeniewski and Callewaert
[19]. Briefly, following stimulation of HECs with 1,5,10,
and 25 µg/ml MAA-Alb or media only (control) for 3 and
24 hours, the HECs were centrifuged (200 × g, 10 min)
and a 100 µl aliquot of the HEC supernatant was trans-
ferred to the corresponding wells of flat-bottomed micro-
titer plates. Subsequently, 100 µl of a freshly prepared
lactic acid dehydrogenase substrate mixture [5.4 × 10-2 lac-
tate (Acros Organics, New Jersey, USA), 6.6 × 10-4 M 2p-
iodophenyl-3p-nitrophenyl tetrazolium chloride (Acros),
2.8 × 10-4 M phenazine methosulfate (Acros), and 1.3 ×
10-3M nicotineamide nucleotide NAD in 0.2 M Tris
buffer, pH 8.2 (Sigma)] was added to each well. The plates
were incubated in the dark at room temperature for 10
min and the reaction stopped by the addition of 50 µl/
well of a 1 M HCl solution. A microtiter plate reader (MR
7000, Dynatech Labs, Inc., Chantilly, VA) was used to
monitor the resultant light absorbance at 490 nm while
630 nm was used as reference. LDH activity, expressed as
change in absorbance/min, was calculated with Biolinx
2.21 software (Dynatech) on an IBM compatible compu-
ter. Percentage necrosis of the HECs was determined by
the following formula: % Necrosis = (E-S)/(M-S) × 100
[19], where E is the optical density (OD) of the experi-
mentally induced release of LDH activity from the HECs
incubated in the presence of the various concentrations of
MAA-Alb, S is the spontaneous release of LDH activity
(OD) from HECs incubated with media only, and M is the
maximal release of LDH activity (OD) determined by
total HEC necrosis induced by exposure to 10% Triton X-
100 (Fisher Scientific, Fair Lawn, NJ) [19].
Endotoxin assay for LPS contamination
Prior to any stimulation all ligands, buffers, and media
were tested for LPS content, which could influence the lev-
els of background cytokine secretion. Samples were mon-
itored for endotoxin using a Limulus Amebocyte Lysate
assay from BioWhittaker (Walkersville, MD). Those sam-
ples contaminated with LPS at concentrations greater than
0.1 ng/ml were not utilized in these studies.
MAA-Alb stimulation of HECs
HECs were washed on the day of the experiment with
M199-F12 without serum and allowed to incubate for 1
hour to remove excess serum components. Following this
incubation period, cells were stimulated with: 5 µg/ml
Alb, MAA-Alb, LPS, and 10 µM Hexyl-MAA (a synthetic
analog to the MAA-adduct) in serum free M199-F12 for 3
hours. Supernatant was collected and frozen at -70
degrees until assayed using a commercially available TNF-
α  ELISA kit.
TNF-alpha ELISA
Quantification of TNF-α  levels of the HEC supernatants
was performed with a Factor-Test-X ™ rat TNF-α  ELISA kit
(Genzyme Diagnostics, Cambridge, MA), which employs
a multiple antibody sandwich principle. The ELISA kit was
developed, stopped and read at 450 nm on a MR7000
plate reader using BIOLINX ™ software. Final concentra-
tions of TNF-α  is expressed in pg/ml.
Statistical analysis
All results are reported as means ± Standard Deviation
(SD). Analysis of variance (ANOVA) was used to compare
means between treatment groups. Dunnett's two-tailed t-
test was used to determine if any pre-treatment was signif-
icantly different when compared to the unpretreated
(control) group of similar diet and in vitro stimulantBMC Anesthesiology 2005, 5:3 http://www.biomedcentral.com/1471-2253/5/3
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In an effort to determine liver damage from the adminis-
tration of halothane and the MAA-adduct, serum from
these animals were collected and assayed for the release of
the serum transaminases, ALT and AST. Results indicated
no difference between the animals injected with Alb,
halothane, MAA-Alb, or halothane + MAA-Alb. There was
a slight increase in ALT/AST levels in the ethanol-fed ani-
mals, yet these results were determined to be insignificant.
Effects of increasing concentrations of MAA-Alb on in vitro 
HEC cell death
In order to determine what concentrations of MAA-Alb
would result in cell death of HECs, cells were isolated
from chow-fed rats and stimulated with increasing doses
of the antigen. As shown in Table 1, HECs incubated with
media alone, 1 and 5 µg/ml of MAA-Alb had little effect
on % cell death after 3 and 24 hours of incubation. How-
ever, both 10 and 25 µg/ml of MAA-Alb had a significant
increase in cell death over the control and lower concen-
trations of the same antigen. There was a statistical differ-
ence in the amount of cell death observed when HECs
were exposed to10 µg/ml for 24 hours as compared to the
3 hour stimulation period. However, these differences
were not observed with 25 µg/ml of MAA-Alb. For these
reasons, 5 µg/ml of MAA-Alb was chosen as the optimum
concentration for use in the remainder of the experiments
in this manuscript.
Effects of pre-treatment with halothane on TNF-α  release 
by HECs
In order to determine the effects of halothane pre-treat-
ment on the release of TNF-α  by HECs, the cells were iso-
lated from pair and ethanol-fed rats that had been injected
as previously described in the Materials and Methods with
one of the following; Alb, halothane, MAA-Alb, or both
halothane and MAA-Alb. The isolated HECs were stimu-
lated in vitro with Alb, MAA-Alb, LPS, or Hexyl-MAA (a
synthetic analog to MAA). As shown in Figure 1, HECs
from ethanol-fed rats injected with MAA-Alb + halothane
and stimulated with 5 µg/ml of Alb significantly (P <
0.01) increased the amount of TNF-α  release when com-
pared to animals injected with Alb. Increases in TNF-α
release were observed in Alb, halothane, and MAA-Alb +
halothane injected ethanol-fed animals in comparison to
the pair-fed controls (P < 0.05). The most significant
increase was demonstrated in the MAA + halothane
injected ethanol rats when compared to the halothane or
MAA-Alb injected animals (P < 0.001). As a positive con-
trol, LPS was used as the stimulating antigen, (Figure 2)
and found to increase TNF-α  secretion in the ethanol-fed
animals as previously shown by others [20]. There was an
increase over the Alb control in animals injected with
halothane, MAA-Alb, and MAA + halothane (P < 0.05).
Pair and ethanol-fed rats injected with the above antigens
increased TNF-α  release 3 fold in response to stimulation
with MAA-Alb in comparison to the Alb or LPS stimulated
Table 1: The percentage of cell death of heart endothelial cells (HECs) after stimulation with MAA Alb as determined by LDH release.
Time 10 µg/ml Alb 1 µg/ml MAA-Alb 5 µg/ml MAA-Alb 10 µg/ml MAA-Alb 25 µg/ml MAA-Alb
3 hours 1.8 ± 0.37 2.8 ± 0.55 2.6 ± 0.68 7.5 ± 0.70* 11.2 ± 0.58*
24 hours 2.6 ± 0.67 3.2 ± 0.58 3.0 ± 0.89 13.3 ± 0.53* 13.3 ± 0.71*
Results are expressed as means +/- SD for 6 determinations in each group. Values different from the media control are indicated (*) at P < 0.05.
Alb-stimulated release of TNF-α  by HECs isolated from pair  and ethanol-fed rats immunized with Alb, halothane, MAA- Alb, or halothane + MAA-Alb Figure 1
Alb-stimulated release of TNF-α  by HECs isolated from pair 
and ethanol-fed rats immunized with Alb, halothane, MAA-
Alb, or halothane + MAA-Alb. Results are expressed as 
means +/- SD for 5 experiments. Values different from Alb 
are indicated (*) at P < 0.01. Values different from the pair-
fed control group are indicated (+) at P < 0.05. Values differ-
ent from Halothane or MAA-Alb injected animals are indi-
cated at (#) P < 0.001.BMC Anesthesiology 2005, 5:3 http://www.biomedcentral.com/1471-2253/5/3
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HEC. As shown in Figure 3, increases in TNF-α  release was
demonstrated in the halothane, MAA-Alb, and halothane
+ MAA-Alb rat HECs after stimulation with MAA-Alb as
compared to the Alb injected rat HECs (P < 0.001). When
comparing the four groups of rats, TNF-α  release was
increased in HECs from ethanol-fed rats over the pair-fed
controls (P < 0.001). Ethanol-fed rats injected with
halothane or MAA-Alb had similar effects on HEC secre-
tion of TNF-α , while MAA-Alb + halothane together had a
3 fold increase over halothane or MAA-Alb alone (P <
0.001). This synergistic response was also observed in the
pair-fed controls for the MAA-Alb + halothane injected rat
HECs. As witnessed in Figure 4, Hexyl-MAA (the synthetic
analog of MAA) stimulated HECs similar to that of MAA-
Alb. Increases in TNF-α  secretion is witnessed in the etha-
nol-fed rats for all the experimental conditions (P <
0.001). There is a 2–3 fold increase in groups injected with
halothane, MAA-Alb, or halothane + MAA-Alb over the
Alb injected control (P < 0.001). The most significant
increase is the 2 fold increase in the MAA-Alb + halothane
injected ethanol-fed rats (P < 0.001). These data show an
additive effect using the combination of both antigens.
Discussion
Tumor necrosis factor-alpha (TNF-α ), the most proximal
pro-inflammatory cytokine mediator released following
LPS (endotoxin) stimulation, induces an inflammatory
LPS-stimulated release of TNF-α  by HECs isolated from pair  and ethanol-fed rats immunized with Alb, halothane, MAA- Alb, or halothane + MAA-Alb Figure 2
LPS-stimulated release of TNF-α  by HECs isolated from pair 
and ethanol-fed rats immunized with Alb, halothane, MAA-
Alb, or halothane + MAA-Alb. Results are expressed as 
means +/- SD for 5 experiments. Values different from Alb 
are indicated (*) at P < 0.05. Values different from the pair-
fed control group are indicated (+) at P < 0.05.
MAA-Alb-stimulated release of TNF-α  by HECs isolated  from pair and ethanol-fed rats immunized with Alb, haloth- ane, MAA-Alb, or halothane + MAA-Alb Figure 3
MAA-Alb-stimulated release of TNF-α  by HECs isolated 
from pair and ethanol-fed rats immunized with Alb, haloth-
ane, MAA-Alb, or halothane + MAA-Alb. Results are 
expressed as means +/- SD for 5 experiments. Values differ-
ent from the Alb injected group are indicated at (*) P < 
0.001. Values different from pair-fed control group are indi-
cated at (+) P < 0.001. Values different from Halothane or 
MAA-Alb injected animals are indicated at (#) P < 0.001.
Hexyl-MAA-Alb-stimulated release of TNF-α  by HECs iso- lated from pair and ethanol-fed rats immunized with Alb,  halothane, MAA-Alb, or halothane + MAA-Alb Figure 4
Hexyl-MAA-Alb-stimulated release of TNF-α  by HECs iso-
lated from pair and ethanol-fed rats immunized with Alb, 
halothane, MAA-Alb, or halothane + MAA-Alb. Results are 
expressed as means +/- SD for 6 experiments. Values differ-
ent from the Alb injected group are indicated at (*) P < 
0.001. Values different from pair-fed control group are indi-
cated at (+) P < 0.001. Values different from Halothane or 
MAA-Alb injected animals are indicated at (#) P < 0.001.BMC Anesthesiology 2005, 5:3 http://www.biomedcentral.com/1471-2253/5/3
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response through several mechanisms, including
increased neutrophil-endothelial cell adherence,
increased endogenous nitric oxide production [21], and
the stimulation of the production and release of other
pro-inflammatory cytokines, including interleukin-8 (IL-
8) [22]. Recently, the role of TNF-α  in the process of apop-
tosis (cell death) has been demonstrated [23]. For exam-
ple, while apoptosis occurs naturally in the liver at a low
and controlled rate, an increased rate of apoptosis is
observed following increased cellular TNF-α  concentra-
tion. The direct correlation between TNF-α  concentrations
and the rate of apoptosis has been described in several
types of liver diseases characterized by cell necrosis and
death [24]. Apoptosis has also been demonstrated in heart
endothelial cells in response to TNF-α  and Interleukin-18
[25,26]. Cell death experiments demonstrate that the
MAA-adduct caused cell death only at concentrations of
10 µg/ml or greater (Table 1). Since TNF-α  may cause cell
death, [24] the significant increase in the percentage of
HEC cell death following stimulation with 10 and 25 µg/
ml of MAA-Alb may be due to the direct toxicity of the
MAA-adduct or indirectly due to MAA-adduct-induced
TNF-α  release. Further studies will be required to clarify
this issue. Ohki et al [27] reported, consistent with the
results of our study, that ethanol fed rats demonstrate
greater TNF-α  release when exposed to LPS, with the
increased TNF-α  release following ethanol feeding caused
increased neutrophil-endothelial adherence. Other
investigators have similarly demonstrated increased neu-
trophil-endothelial adherence induced by ethanol, sug-
gesting ethanol ingestion induces an inflammatory injury
[28]. Since the MAA-adduct is a primary metabolic end
product of ethanol metabolism, our demonstration that
this adduct induces TNF-α  release and that alcohol feed-
ing potentiates endotoxin-induced TNF-α  release is con-
sistent with the understanding that alcohol adduct
induced TNF-α  release may play a significant role in alco-
hol induced solid organ injury [20].
MDA has been detected in guinea pig heart tissue follow-
ing exposure to halothane [29]. Also interesting is that cir-
culating antibodies to cardiac protein-acetaldehyde
adducts have been found in alcoholic heart muscle dis-
ease [30]. If AA from alcohol metabolism and MDA from
halothane are present in heart tissue, the possibility of
MAA-adduct formation is likely. The majority of adducts
formed when acetaldehyde reacts with proteins for short
time periods are unstable AA-protein adducts. With time,
unstable AA-adducts stabilize and can form an irreversible
adduct. This irreversible, stable adduct has been demon-
strated to be the MAA-adduct [15]. These MAA-adducts
have also been found in atherosclerotic human aortic
heart tissue [9], providing a mechanism of heart tissue
damage. Heavy alcohol consumption can accelerate
human atherosclerotic heart disease [31], making MAA-
adducts a possible candidate for this process.
Increased TNF-α  levels have similarly been implicated in
other disease states, like end-stage heart disease and
intractable heart failure, by the promotion of monocyte
dysfunction and death [32]. Since TFA-adduct production
is induced with a single dose of halothane and persists in
measurable concentrations in rat heart for greater than 90
hours (but less than 10 days), [8,33] the possibility for
cross-reaction with MAA-adducts is plausible. These
experiments demonstrated that halothane and the MAA-
adduct-induced HEC TNF-α  release in a synergistic man-
ner. In support of this data, Trudell et al [3] demonstrated
that antibodies raised against AA-adducts and TFA-
adducts cross-react, suggesting that the immunologic
properties of both adducts may be similar. This data sug-
gests that similar immunologic mechanisms may be
shared by both halothane hepatitis and ethanol-induced
liver injury. The data reported in this study demonstrates
that halothane pre-treatment will potentiate the MAA-
adduct induced TNF-α  release in vitro of HECs. This gives
support to the Trudell et al [3] demonstration that the AA-
adducts and TFA-adducts induce organ injury by the
release of chemoattractants during the metabolism of eth-
anol and halothane, resulting in the recruitment of
inflammatory cells as the initial step in the initiation of
organ injury. TNF-α  production and release is a primary
biologic mechanism in inflammatory cell recruitment
since TNF-α  induces the production of IL-8 [34].
Interleukin-8 is the primary cytokine responsible for the
promotion of inflammatory cell (neutrophils and mono-
cytes) chemotaxis (migration) and recruitment toward an
inflammatory site [34]. Further studies need to be done in
order to prove that the TFA-adduct and MAA-adduct cross-
react.
Conclusion
In conclusion, the current study demonstrates that haloth-
ane or MAA-Alb pre-treatment potentiates the HEC TNF-
α  release following MAA-adduct stimulation of ethanol-
fed rats when compared to control pair-fed rats. This sug-
gests that the TFA-adduct resulting from the metabolism
of halothane increases the inflammatory response, as
measured by TNF-α  release, following LPS and alcohol
(MAA-Alb) adduct stimulation, and that this TNF-α
release may contribute to post-halothane exposure solid
organ injury. The data also suggest that solid organ injury
following halothane administration may be enhanced by
prior ethanol consumption. This could help explain the
increased risk of cardiovascular disease following exces-
sive alcohol consumption. Finally, these results demon-
strate that the combination of ethanol consumption and
halothane exposure may enhance the possibility of the
development of the sepsis syndrome, since increasedBMC Anesthesiology 2005, 5:3 http://www.biomedcentral.com/1471-2253/5/3
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systemic concentrations of TNF-α  induced by endotoxin is
a primary cause of that clinical condition.
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